AI-Powered Digital Therapy Platform for Children with Brain based Visual Impairment (CVI)

Cerebral Visual Impairment (CVI) affects 36 million children globally and is the leading cause of childhood visual impairment. Unlike eye conditions, CVI results from brain damage affecting how children process what they see. Their eyes are healthy, but the brain cannot interpret visual information, making the world appear chaotic. It is the most common visual condition in children with Cerebral Palsy and Down Syndrome. Early intervention during the first five years, when neuroplasticity is at peak, can significantly improve outcomes. However, 80% of children miss this critical window. Specialised therapists are concentrated in urban hospitals, leaving rural families without access. Traditional therapy costs 4 lakh annually in India, and mothers spend 3-5 hours daily travelling to clinics, often leaving employment to manage care. Therapists spend one-third of their time preparing customised materials, limiting how many children they can serve. Long waiting lists mean children lose precious months during optimal intervention. The result: children who need therapy most, those in remote areas and low-income families, are least likely to receive it, leading to lifelong disability, reduced independence, and economic strain on families.

Grailmaker Innovations is a social enterprise founded in 2021 in Hyderabad, India. We develop assistive technology for children with disabilities, with our flagship product Vision Nanny addressing Cerebral Visual Impairment (CVI), the leading cause of childhood visual impairment globally. Our founding team combines clinical expertise in vision rehabilitation with technology and product development. The company emerged from work at LV Prasad Eye Institute, where our co-founders witnessed the gap between therapy children need and what families can access. Mothers travelled long hours to clinics for therapy, while therapists spent hours customising the activities for each child. Vision Nanny was built through collaboration with rehabilitation specialists, tested iteratively with children and caregivers, and designed for resource-limited settings. The platform has been clinically validated through partnerships with LV Prasad Eye Institute (a WHO Collaborating Centre), and is widely used by therapists and parents from Dr. Shroff's Charity Eye Hospital, Akshadhaa Foundation and Manipal Hospitals. Beyond clinical settings, we have pioneered community-based delivery through partnerships with Vision Aid, training community health workers in rural Odisha to deliver therapy in 21 villages, reaching 3,000 children who had never accessed vision therapy before. Our work has been recognised through Forbes 30 Under 30 Asia 2025 (Social Impact), Bayer Women Entrepreneur Award 2025, and Halcyon Equity Tech Fellowship 2024. We have published peer-reviewed research in the Indian Journal of Ophthalmology and spoken at G20 side events on disability inclusion. Grailmaker operates as a for-profit social enterprise with a B2B, B2C, and B2G model, approaching operational sustainability while reaching underserved communities.